Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Return on Capital Employed (2017 - 2025)

Historic Return on Capital Employed for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to 0.02%.

  • Organogenesis Holdings' Return on Capital Employed rose 100.0% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.0% for FY2024, which is 400.0% down from last year.
  • Organogenesis Holdings' Return on Capital Employed amounted to 0.02% in Q3 2025, which was up 100.0% from 0.06% recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Return on Capital Employed peaked at 0.32% during Q2 2021, and registered a low of 0.06% during Q1 2025.
  • For the 5-year period, Organogenesis Holdings' Return on Capital Employed averaged around 0.08%, with its median value being 0.05% (2023).
  • As far as peak fluctuations go, Organogenesis Holdings' Return on Capital Employed surged by 5400bps in 2021, and later plummeted by -1900bps in 2022.
  • Organogenesis Holdings' Return on Capital Employed (Quarter) stood at 0.22% in 2021, then crashed by -74bps to 0.06% in 2022, then crashed by -44bps to 0.03% in 2023, then plummeted by -110bps to 0.0% in 2024, then crashed by -552bps to 0.02% in 2025.
  • Its last three reported values are 0.02% in Q3 2025, 0.06% for Q2 2025, and 0.06% during Q1 2025.